Aug. - Sept. 2015

17



Latest Interesting Articles
  (Endovascular Today)
August 19, 2015—Boston Scientific Corporation announced that the company has received US Food and Drug Administration (FDA) approval for the Innova vascular self-expanding stent system to treat peripheral artery disease (PAD) in the superficial femoral artery (SFA) or proximal popliteal artery (PPA). The company has commenced a full commercial launch of the Innova stent system in the United States. The Innova stent system received European CE Mark approval in May 2012.
Read more.



•
•
•

Copyright © 2015, APVS. All rights reserved.
Dr. (Prof.) N. N. Khanna
MD, DM, FRCP, FESC, FSCAI, FCCP, FAPSIC, FIMSA, FEISI, FICC, FIAMS, FCSI, FICP
Chairman, Asia Pacific Vascular Society
Sr. Consultant, Interventional Cardiology & Vascular Interventions
Advisor- Apollo Group of Hospitals
Indraprastha Apollo Hospitals, New Delhi

Email ID: nnkhannaapvic@gmail.com